Literature DB >> 27535051

Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.

Zaili Yang1, Xiaoning Wang2, Xiumei Chi3, Fanfan Zhao2, Jinxu Guo2, Pengjuan Ma2, Jin Zhong2, Junqi Niu3, Xiaoyu Pan2, Gang Long4.   

Abstract

Hepatitis C virus (HCV) is a major cause of chronic liver disease, infecting approximately 170 million people worldwide. HCV assembly is tightly associated with the lipoprotein pathway. Exchangeable apolipoprotein E (apoE) is incorporated on infectious HCV virions and is important for infectious HCV virion morphogenesis and entry. Moreover, the virion apoE level is positively correlated with its ability to escape E2 antibody neutralization. However, the role of apoE exchange in the HCV life cycle is unclear. In this study, the relationship between apoE expression and cell permissiveness to HCV infection was assessed by infecting apoE knockdown and derived apoE rescue cell lines with HCV. Exchange of apoE between lipoproteins and HCV lipoviral particles (LVPs) was evaluated by immunoprecipitation, infectivity testing, and viral genome quantification. Cell and heparin column binding assays were applied to determine the attachment efficiency of LVPs with different levels of incorporated apoE. The results showed that cell permissiveness for HCV infection was determined by exogenous apoE-associated lipoproteins. Furthermore, apoE exchange did occur between HCV LVPs and lipoproteins, which was important to maintain a high apoE level on LVPs. Lipid-free apoE was capable of enhancing HCV infectivity for apoE knockdown cells but not apoE rescue cells. A higher apoE level on LVPs conferred more efficient LVP attachment to both the cell surface and heparin beads. This study revealed that exogenous apoE-incorporating lipoproteins from uninfected hepatocytes safeguarded the apoE level of LVPs for more efficient attachment during HCV infection. IMPORTANCE: In this study, a neglected but important role of apoE exchange in HCV LVP infectivity after virus assembly and release was identified. The data indicated that apoE expression level in uninfected cells is important for high permissiveness to HCV infection. Secreted apoE-associated lipoprotein specifically enhances infection of HCV LVPs. apoE exchange between HCV LVP and lipoproteins is important to maintain an adequate apoE level on LVPs for their efficient attachment to cell surface. These data defined for the first time an extracellular role of exchangeable apoE in HCV infection and suggested that exchangeable apolipoproteins reach a natural equilibrium between HCV LVPs and lipoprotein particles, which provides a new perspective to the understanding of the heterogeneity of HCV LVPs in composition.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27535051      PMCID: PMC5068516          DOI: 10.1128/JVI.01353-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.

Authors:  Budhaditya Mazumdar; Arup Banerjee; Keith Meyer; Ranjit Ray
Journal:  Hepatology       Date:  2011-07-25       Impact factor: 17.425

Review 2.  New hepatitis C therapies: the toolbox, strategies, and challenges.

Authors:  Jean-Michel Pawlotsky
Journal:  Gastroenterology       Date:  2014-03-12       Impact factor: 22.682

Review 3.  The ins and outs of hepatitis C virus entry and assembly.

Authors:  Brett D Lindenbach; Charles M Rice
Journal:  Nat Rev Microbiol       Date:  2013-09-10       Impact factor: 60.633

4.  Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins.

Authors:  Ji-Young Lee; Eliana G Acosta; Ina Karen Stoeck; Gang Long; Marie-Sophie Hiet; Birthe Mueller; Oliver T Fackler; Stephanie Kallis; Ralf Bartenschlager
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

5.  The association of hepatitis C virus glycoproteins with apolipoproteins E and B early in assembly is conserved in lipoviral particles.

Authors:  Audrey Boyer; Amélie Dumans; Elodie Beaumont; Loïc Etienne; Philippe Roingeard; Jean-Christophe Meunier
Journal:  J Biol Chem       Date:  2014-05-16       Impact factor: 5.157

6.  Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin.

Authors:  Sylvie Larrat; Sophie Vallet; Sandra David-Tchouda; Alban Caporossi; Jennifer Margier; Christophe Ramière; Caroline Scholtes; Stéphanie Haïm-Boukobza; Anne-Marie Roque-Afonso; Bernard Besse; Elisabeth André-Garnier; Sofiane Mohamed; Philippe Halfon; Adeline Pivert; Hélène LeGuillou-Guillemette; Florence Abravanel; Matthieu Guivarch; Vincent Mackiewicz; Olivier Lada; Thomas Mourez; Jean-Christophe Plantier; Yazid Baazia; Sophie Alain; Sebastien Hantz; Vincent Thibault; Catherine Gaudy-Graffin; Dorine Bouvet; Audrey Mirand; Cécile Henquell; Joel Gozlan; Gisèle Lagathu; Charlotte Pronier; Aurélie Velay; Evelyne Schvoerer; Pascale Trimoulet; Hervé Fleury; Magali Bouvier-Alias; Etienne Brochot; Gilles Duverlie; Sarah Maylin; Stéphanie Gouriou; Jean-Michel Pawlotsky; Patrice Morand
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

Review 7.  From non-A, non-B hepatitis to hepatitis C virus cure.

Authors:  Jean-Michel Pawlotsky; Jordan J Feld; Stefan Zeuzem; Jay H Hoofnagle
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

8.  Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.

Authors:  Shufeng Liu; Kevin D McCormick; Wentao Zhao; Ting Zhao; Daping Fan; Tianyi Wang
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

9.  Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model.

Authors:  Sara Calattini; Floriane Fusil; Jimmy Mancip; Viet Loan Dao Thi; Christelle Granier; Nicolas Gadot; Jean-Yves Scoazec; Mirjam B Zeisel; Thomas F Baumert; Dimitri Lavillette; Marlène Dreux; François-Loïc Cosset
Journal:  J Biol Chem       Date:  2015-07-29       Impact factor: 5.157

10.  Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture.

Authors:  Kyung-Soo Chang; Jieyun Jiang; Zhaohui Cai; Guangxiang Luo
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

View more
  18 in total

1.  Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.

Authors:  Fanfan Zhao; Ting Zhao; Libin Deng; Dawei Lv; Xiaolong Zhang; Xiaoyu Pan; Jun Xu; Gang Long
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

2.  Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.

Authors:  Zhihua Li; Yadong Li; Yanwei Bi; Hui Zhang; Yufeng Yao; Qihan Li; Wei Cun; Shaozhong Dong
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 3.  Current progress in host innate and adaptive immunity against hepatitis C virus infection.

Authors:  Jijing Shi; Yuanyuan Li; Wenxian Chang; Xuexiu Zhang; Fu-Sheng Wang
Journal:  Hepatol Int       Date:  2017-06-22       Impact factor: 6.047

Review 4.  Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

Authors:  Emilie Crouchet; Thomas F Baumert; Catherine Schuster
Journal:  Expert Rev Proteomics       Date:  2017-06-30       Impact factor: 4.250

Review 5.  Regulated Entry of Hepatitis C Virus into Hepatocytes.

Authors:  Zhijiang Miao; Zhenrong Xie; Jing Miao; Jieyu Ran; Yue Feng; Xueshan Xia
Journal:  Viruses       Date:  2017-05-09       Impact factor: 5.048

Review 6.  Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design.

Authors:  Florian Wrensch; Emilie Crouchet; Gaetan Ligat; Mirjam B Zeisel; Zhen-Yong Keck; Steven K H Foung; Catherine Schuster; Thomas F Baumert
Journal:  Front Immunol       Date:  2018-06-21       Impact factor: 8.786

Review 7.  Hepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder.

Authors:  Samantha A Yost; Yuanyuan Wang; Joseph Marcotrigiano
Journal:  Front Immunol       Date:  2018-08-24       Impact factor: 7.561

Review 8.  Molecular interactions at the surface of extracellular vesicles.

Authors:  Edit I Buzás; Eszter Á Tóth; Barbara W Sódar; Katalin É Szabó-Taylor
Journal:  Semin Immunopathol       Date:  2018-04-16       Impact factor: 9.623

9.  Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose Parameters.

Authors:  Mary-Anne Doyle; Chrissi Galanakis; Erin Mulvihill; Angela Crawley; Curtis L Cooper
Journal:  Cells       Date:  2019-03-15       Impact factor: 6.600

10.  Hepatitis C Virus Lipoviroparticles Assemble in the Endoplasmic Reticulum (ER) and Bud off from the ER to the Golgi Compartment in COPII Vesicles.

Authors:  Gulam H Syed; Mohsin Khan; Song Yang; Aleem Siddiqui
Journal:  J Virol       Date:  2017-07-12       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.